Bionano Genomics (BNGO) Gross Margin (2017 - 2026)

Bionano Genomics has disclosed Gross Margin across 10 years of filings, most recently posting 52.8% for Q2 2026.

• In Q2 2026, Gross Margin rose 116.0% year-over-year to 52.8%; the TTM figure through Jun 2026 stood at 47.5% (up 2572.0% YoY), while the FY2025 annual figure was 46.25%, up 4502.0% from the prior year.
• Gross Margin came in at 52.8% for Q2 2026 at Bionano Genomics, up from 48.63% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 98.08% in Q4 2024 to a low of 139.07% in Q3 2024.
• Average Gross Margin over 5 years is 27.92%, with a median of 30.85% recorded in 2023.
• Year-over-year, Gross Margin plunged 16858 bps in 2024 and surged 18482 bps in 2025.
• Over 5 years, Gross Margin stood at 21.97% in 2022, then advanced by 3 bps to 22.74% in 2023, then soared by 331 bps to 98.08% in 2024, then sank by 56 bps to 42.75% in 2025, then rose by 24 bps to 52.8% in 2026.
• Per Business Quant data, the three most recent Gross Margin figures were 52.8% in Q2 2026, 48.63% in Q1 2026, and 42.75% in Q4 2025.